Vesedaganat: vizsgálatok itt: Csehország
7 of 7 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)
- Where
- Brno-Stred, Hradec Králové, Olomouc, Ostrava, Prague, Prague 2
- Életkor
- 18 év and over
- People
- 758 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07489495 · EU 2024-516993-31-00 - 3. fázisTaking peopleA Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
- Where
- Brno-Stred, České Budějovice, Hradec Králové, Olomouc, Ostrava, Prague, Prague 2
- Életkor
- 18 év and over
- People
- 904 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07227402 · EU 2024-517136-21-00 - 3. fázisTaking peopleA clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)
- Where
- Brno-Stred, Olomouc, Prague
- Életkor
- 18 év and over
- People
- 134 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to join2025-524160-38-00 - 3. fázisTaking peopleStudy of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
- Where
- Brno, Brno-Stred, České Budějovice, Hradec Králové, Olomouc, Prague
- Életkor
- 18 év and over
- People
- 720 worldwide
- Run by
- Arcus Biosciences, Inc.
See details and how to joinNCT07011719 · EU 2024-515023-11-00 - 1/2. fázisNot yet taking people in CsehországA Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
- Where
- Brno-Stred, Hradec Králové, Prague
- Életkor
- 18 év and over
- People
- 474 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07293351 · EU 2026-527163-15-00 - 3. fázisTaking peopleCARE1: FIRST LINE RANDOMISED STUDY PLATFORM TO OPTIMIZE TREATMENT IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
- Where
- Brno-Stred, Novy Hradec Kralove, Olomouc, Plzen 23, Prague
- Életkor
- 18 év and over
- People
- 1373 worldwide
- Run by
- Institut Gustave Roussy
See details and how to join2023-503317-29-00 - 3. fázisTaking peopleCARE1 Pragmatic Clinical Trial
- Where
- Brno, Hradec Králové, Olomouc, Prague
- Életkor
- 18 év and over
- People
- 1250 worldwide
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT06364631